Jun 09, 2022 / 08:00PM GMT
David Howard Windley - Jefferies LLC, Research Division - MD & Equity Analyst
All right. Welcome, everybody. I'm Dave Windley with Jefferies Health Equity Research. Glad to be here after my parole. It's great to see everybody and glad we could in person for our New York Healthcare Conference here in June of 2022.
I'm very pleased to have with us for our next presentation or fireside chat session West Pharmaceutical Services. The company is a leading player in the containment of injectable drug products. And representing the company is the company's CFO, Bernard Birkett; and head of IR, Quin Lai. So thank you, gentlemen, for being here with us.
Questions and Answers:
David Howard Windley - Jefferies LLC, Research Division - MD & Equity AnalystI'm going to fire off just dig right into questions. Bernard, your high value products and the transition to those has really been a theme for the company for a long time. But in the last maybe 2 or 3 years, the kind of traction of those or the inflection of those seems to have kind of taking on the